Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA campus

Executive Summary

General Services Administration announces intention to acquire land on behalf of FDA in Montgomery County, Md., through an advertisement in the Dec. 14 Washington Post. Part of FDA's effort to consolidate its Washington-area facilities into a two-site campus, the Montgomery County site will house the Center for Drug Evaluation and Research and the Center for Devices and Radiological Health. GSA is seeking "no less than 133 contiguous buildable acres" that are adequately zoned to accomodate 1 mil. gross sq. ft. of office and lab space and 1,330 parking spaces. GSA wants responses by Jan. 29.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel